UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Proteobacteria: A Common Factor in Human Diseases

BioMed research international, 2017-01, Vol.2017 (2017), p.1-7

2017

Volltextzugriff (PDF)

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide

Gastroenterology research and practice, 2017-01, Vol.2017 (2017), p.1-11

2017

Volltextzugriff (PDF)

Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment

Beneficial microbes, 2020-10, Vol.11 (6), p.519-526

2020

Volltextzugriff (PDF)

Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions

Alimentary pharmacology & therapeutics, 2018-07, Vol.48 (2), p.152-159

2018

Volltextzugriff (PDF)

The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors

European review for medical and pharmacological sciences, 2015, Vol.19 (6), p.1068

2015

Volltextzugriff (PDF)

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis

Transplantation proceedings, 2016-03, Vol.48 (2), p.402-407

2016

Volltextzugriff (PDF)

Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19

European review for medical and pharmacological sciences, 2020-07, Vol.24 (13), p.7506

2020

Volltextzugriff (PDF)

Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey

European review for medical and pharmacological sciences, 2022-10, Vol.26 (19), p.7277

2022

Volltextzugriff (PDF)

Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period

European review for medical and pharmacological sciences, 2021-09, Vol.25 (18), p.5826

2021

Volltextzugriff (PDF)

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease

Digestive diseases (Basel), 2016-01, Vol.34 (3), p.202-209

2016

Volltextzugriff (PDF)

Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: a multidisciplinary management experience

European review for medical and pharmacological sciences, 2020-01, Vol.24 (2), p.564

2020

Volltextzugriff (PDF)

A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors

European review for medical and pharmacological sciences, 2020-08, Vol.24 (16), p.8469

2020

Volltextzugriff (PDF)

High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection

European review for medical and pharmacological sciences, 2016, Vol.20 (2), p.297

2016

Volltextzugriff (PDF)

Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication

European review for medical and pharmacological sciences, 2013-11, Vol.17 Suppl 2, p.2

2013

Volltextzugriff (PDF)

Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries

European review for medical and pharmacological sciences, 2016-09, Vol.20 (18), p.3891

2016

Volltextzugriff (PDF)

P910 Emerging role of IL-33/ST2 and Gut Microbiota axis in the inflammatory process of ulcerative colitis patients with ileal pouch-anal anastomosis

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i1023-i1023

2023

Volltextzugriff (PDF)

P099 IL-33 activates CD73-expressing cells promoting tumorigenesis during colitis-associated colorectal cancer

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i261-i262

2023

Volltextzugriff (PDF)

The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease

Expert opinion on investigational drugs, 2018-06, Vol.27 (6), p.543-551

2018

Volltextzugriff (PDF)

P828 Incidence and predictors of arterial and venous thromboembolic events in hospitalized patients with inflammatory bowel disease compared to patients with acute infective gastroenteritis and colitis: a propensity score-matched study

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i961-i961

2023

Volltextzugriff (PDF)

P881 Real-life vs trial access to biologic therapy differences: a 2019-2020 experience in an Italian tertiary IBD center

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1624-i1624

2024

Volltextzugriff (PDF)

P1213 The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patients

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i2157-i2157

2024

Volltextzugriff (PDF)

P363 Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i770-i772

2024

Volltextzugriff (PDF)

P750 Endoscopic balloon dilation associated with biological therapy in Crohn's Disease strictures: a single center experience

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1401-i1402

2024

Volltextzugriff (PDF)

P096 Human extrachromosomal circular DNA is an emerging biomarker in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i375-i375

2024

Volltextzugriff (PDF)

P460 The POCER index: application of a novel endoscopic score in a real-life cohort of patients with Crohn's disease after surgery

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i928-i928

2024

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Pharmacology & Pharmacy
(11)
Female
(7)
Inflammatory Bowel Disease
(6)
Male
(6)
Adult
(5)
Breath Tests
(5)
Microbiota
(5)
Bacteria - Metabolism
(4)
Biomarkers - Metabolism
(4)
Gases
(4)
Gastrointestinal Diseases - Diagnosis
(4)
Gastrointestinal Diseases - Metabolism
(4)
Gastrointestinal Diseases - Microbiology
(4)
Gut Microbiota
(4)
Middle Aged
(4)
Predictive Value Of Tests
(4)
Gastroenterology & Hepatology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Proteobacteria: A Common Factor in Human Diseases

Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide

Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment

Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions

The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis

Gastrointestinal symptoms and digestive comorbidities in an Italian cohort of patients with COVID-19

Evaluation of factors associated with trust in telemedicine in patients with inflammatory bowel disease during COVID-19 pandemic: a multicenter cross-sectional survey

Changes in admissions, and hospitalization outcomes of IBD patients in an Italian tertiary referral center over a 13-year period

Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease

Prevalence of cervical HPV and attitude towards cervical screening in IBD patients under immunomodulatory treatment: a multidisciplinary management experience

A transition clinic model for inflammatory bowel disease between two tertiary care centers: outcomes and predictive factors

High dose amoxicillin-based first line regimen is equivalent to sequential therapy in the eradication of H. pylori infection

Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication

Epidemiological evaluation of acute gastroenteritis and therapeutic approaches in Middle East Countries

P910 Emerging role of IL-33/ST2 and Gut Microbiota axis in the inflammatory process of ulcerative colitis patients with ileal pouch-anal anastomosis

P099 IL-33 activates CD73-expressing cells promoting tumorigenesis during colitis-associated colorectal cancer

The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease

P828 Incidence and predictors of arterial and venous thromboembolic events in hospitalized patients with inflammatory bowel disease compared to patients with acute infective gastroenteritis and colitis: a propensity score-matched study

P881 Real-life vs trial access to biologic therapy differences: a 2019-2020 experience in an Italian tertiary IBD center

P1213 The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patients

P363 Multimodal dynamic ultrasound approach as predictor of response in patients with Crohn’s disease treated with ustekinumab

P750 Endoscopic balloon dilation associated with biological therapy in Crohn's Disease strictures: a single center experience

P096 Human extrachromosomal circular DNA is an emerging biomarker in Inflammatory Bowel Disease

P460 The POCER index: application of a novel endoscopic score in a real-life cohort of patients with Crohn's disease after surgery

Suchergebnisse filtern